跳至主要内容
临床试验/NCT07016685
NCT07016685招募中不适用

Prognostic Factors for 90-day Mortality in Patients Undergoing Veno-venous Extracorporeal Membrane Oxygenation for Emergency Thoracic Surgery

Centre Hospitalier Universitaire, Amiens1 个研究点 分布在 1 个国家目标入组 380 人开始时间: 2025年6月1日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
380
试验地点
1
主要终点
90-day all-cause mortality

研究概览

简要总结

Veno-vneous extracorporeal membrane oxygenation (VV-ECMO) is an established support strategy for acute respiratory failure, but its role in the perioperative management of emergency thoracic surgery remains poorly defined. This retrospective, multicenter, observational study aims to assess the clinical outcomes and prognostic factors in this high-risk population. Patients undergoing emergency thoracic procedures requiring VV-ECMO will be compared to a control cohort of patients treated with VV-ECMO for medical respiratory failure. Data will be collected from two French academic centers (CHU Amiens-Picardie and CHU Dijon).

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults ≥ 18 years
  • VV-ECMO initiated during or after emergency thoracic surgery
  • No opposition to data use

排除标准

  • Pregnant women
  • Veno-Arterial ECMO patients
  • Patients under legal protection

结局指标

主要结局

90-day all-cause mortality

时间窗: 90 days

次要结局

  • 90-day mortality in oncologic vs. non-oncologic thoracic surgery(90 days)
  • Postoperative complication rates(90 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验